Clinical trials
Recruiting Phase 3 Hemophilia A trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Hoffmann-La Roche | 2 |
| Emory University | 1 |
| Gritgen Therapeutics Co., Ltd. | 1 |
| Sanofi | 1 |
| Sinocelltech Ltd. | 1 |
| Suzhou Alphamab Co., Ltd. | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 11 |
| Hemophilia B | 4 |
| Hemorrhage | 2 |
| Blood Coagulation Disorders | 1 |
| Coagulation Protein Disorders | 1 |
| Lymphoma, Follicular | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.